用个人参与者数据对时间到事件终点的网络元分析,使用受限平均生存时间回归
Kaiyuan Hua1, Xiaofei Wang1, Hwanhee Hong1
1Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
Biometrical journal. Biometrische Zeitschrift
|February 19, 2025
概括
本研究介绍了使用个人参与者数据 (IPD) 的高级受限平均生存时间 (RMST) 网络元分析 (NMA) 模型. 这些模型允许对治疗效果调节和子组效应进行可靠的评估,以便更好地比较有效性洞察.
科学领域:
- 生物统计学 生物统计学
- 临床流行病学临床流行病学
- 药学指标 (Pharmacometrics) 是一个指标.
背景情况:
- 网络元分析 (NMA) 整合了直接和间接的治疗比较.
- 个人参与者数据 (IPD) 允许进行治疗效果适度分析.
- 由于可解释性,限制平均存活时间 (RMST) 模型是首选的时间到事件数据.
研究的目的:
- 提出新的IPD-NMA模型来分析时间到事件结果.
- 为了使治疗效果适度的评估使用单独的共变量.
- 提高对比治疗有效性和子组效应的理解.
主要方法:
- 开发包含IPD的先进的RMST NMA模型.
- 使用个人级别的共变量进行详细的子组分析.
- 通过广泛的模拟研究和现实世界NMA案例进行评估.
主要成果:
- 拟议的模型有效地纳入了用于调节分析的个别共变量.
- 证明能够提供全面的比较有效性的洞察力.
- 在现实世界NMA中成功应用心房的治疗方法.
结论:
- 先进的IPD-NMA模型比聚合方法更好地分析时间到事件数据.
- 这些模型有助于更深入地了解不同患者亚组的治疗效果.
- 该方法在临床研究中为证据综合提供了有价值的工具.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
122
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
122
Kaplan-Meier Approach
79
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
79
Introduction To Survival Analysis
162
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
162
Censoring Survival Data
56
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
56
Assumptions of Survival Analysis
84
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
84
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321


